Cantor Fitzgerald reiterated coverage on Ocuphire Pharma with a new price target

3/15/21 12:17:36 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Cantor Fitzgerald reiterated coverage of Ocuphire Pharma with a rating of Positive and set a new price target of $20.00 from $15.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OCUP

Date	Price Target	Rating	Analyst
11/24/2021	$26.00	Buy	HC Wainwright & Co.